共 50 条
Factors affecting levodopa effects in Parkinson's disease
被引:0
|作者:
Ogawa, N
[1
]
机构:
[1] Okayama Univ, Sch Med, Inst Mol & Cellular Med, Dept Neurosci, Okayama 7008558, Japan
关键词:
dopamine agonist;
monoamine oxidase-B (MAO-B) inhibitor;
catechol-O-methyltransferase (COMT) inhibitor;
blood-brain barrier;
age at onset;
large neutral amino acids;
gastric acidity;
D O I:
暂无
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Levodopa is the gold standard for the treatment of Parkinson's disease (PD) because of its outstanding clinical efficacy. However, the majority of patients experience various adverse reactions, including the wearing-off phenomenon, the on-off phenomenon, dyskinesia and psychiatric symptoms. The response to levodopa depends not only on the intrinsic responsiveness of the patients, but also on various other important factors including the type of levodopa preparation, its absorption/metabolism, the blood-brain barrier, age at onset of disease and concomitant use of anti-parkinsonian drugs. This review summarizes factors which influence the effects of levodopa in PD, To minimize levodopa-induced adverse reactions and to relieve long-term parkinsonian symptoms,levodopa therapy should be conducted by taking these factors into consideration.
引用
收藏
页码:95 / 101
页数:7
相关论文